Amendment to Simon Wajcenberg Option Grant Agreements dated April 2, 2025
Exhibit 10.1
EDGEMODE, INC.
Attention: Simon Wajcenberg, Optionee
Re: Amendment to Option Grants
Dear Optionee,
Edgemode, Inc. (the “Company”) in consideration of the Optionee’s agreement to convert $50,000 of Optionee’s accrued salary payable under his Company employment agreement hereby amends each of his options to purchase up to: (1) 31,979,352 shares of the Company’s common stock dated January 31, 2022, exercisable at $0.06 per share (the “January 2022 Grants”); (2) 76,619,303 shares of the Company’s common stock dated September 12, 2022, as amended, exercisable at $0.10 per share (the “September 2022 Stock Option Grants”) and (3) 77,000,000 shares of the Company’s common stock dated March 1, 2023 exercisable at $0.04 per share (the “2023 Grants”; the January 2022 Grants, September 2022 Grants and the March 2023 Grants, collectively the “Option Grants”), to reduce the exercise price of the Option Grants to an exercise price of $0.005 per share, as stated herein.
| 1. | Amendment. Section 1 of each of the Option Grants is amended to reduce the Option Price to $0.005 per share. | |
| 2. | No Other Amendment. Except as specifically amended pursuant to this Amendment, the Option Grants remain in full force and effect in accordance with its terms. | |
| 3. | Effectiveness. This Amendment will become effective upon your acknowledgment of the terms and conditions of this Amendment and your delivery to us of a signed counterpart of this Amendment. |
Very truly yours,
/s/ Charlie Faulkner____________________
Charlie Faulkner, Chief Executive Officer
Dated: April 2, 2025
AGREED TO AND ACCEPTED ON APRIL 2, 2025
Optionee
/s/ Simon Wajcenberg__________________
Simon Wajcenberg, Chief Financial Officer
